Skip to content

Oncternal Therapeutics, Inc.: filings

Every Oncternal Therapeutics, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 55 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2024-11-06fiscal Q3 202433890000950170-24-122383
10-Q2024-08-08fiscal Q2 202433890000950170-24-094082
10-Q2024-05-09fiscal Q1 202433670000950170-24-057008
10-K2024-03-07fiscal FY 202335700000950170-24-027984
10-Q2023-11-09fiscal Q3 202333890000950170-23-062132
10-Q2023-08-10fiscal Q2 202333890000950170-23-041395
10-Q2023-05-04fiscal Q1 202331640000950170-23-017928
10-K2023-03-09fiscal FY 202234690000950170-23-007062
10-Q2022-11-03fiscal Q3 202229790000950170-22-021928
10-Q2022-08-09fiscal Q2 202229790000950170-22-016105
10-Q2022-05-05fiscal Q1 202223480000950170-22-007881
10-K2022-03-10fiscal FY 202127540001564590-22-009702
10-Q2021-11-04fiscal Q3 202124610001564590-21-054536
10-Q2021-08-05fiscal Q2 202125650001564590-21-041698
10-Q2021-05-06fiscal Q1 202125510001564590-21-025109
10-K/A2021-03-12fiscal FY 202027530001564590-21-012865
10-K2021-03-11fiscal FY 202027530001564590-21-012588
10-Q2020-11-04fiscal Q3 202027690001564590-20-050576
10-Q2020-08-06fiscal Q2 202027690001564590-20-037842
10-Q2020-05-07fiscal Q1 202027550001564590-20-022300
10-K2020-03-16fiscal FY 201929550001564590-20-011213
10-Q2019-11-08fiscal Q3 201928700001564590-19-041983
10-Q2019-08-09fiscal Q2 201927680001564590-19-031056
10-Q2019-05-10fiscal Q1 201925520001104659-19-028624
10-K2019-03-18fiscal FY 2018281130001047469-19-001382
10-Q2018-11-08fiscal Q3 201824600001104659-18-066993
10-Q2018-08-14fiscal Q2 201824600001104659-18-051957
10-Q2018-05-15fiscal Q1 201824500001104659-18-033234
10-K2018-03-13fiscal FY 2017311540001047469-18-001564
10-Q2017-11-14fiscal Q3 201724590001104659-17-068532
10-Q2017-08-14fiscal Q2 201724590001104659-17-051813
10-Q2017-05-15fiscal Q1 201727550001104659-17-032803
10-K2017-03-24fiscal FY 2016301510001047469-17-001982
10-Q2016-11-07fiscal Q3 201627730001104659-16-155198
10-Q2016-08-09fiscal Q2 201623570001104659-16-138309
10-Q2016-05-10fiscal Q1 201627540001104659-16-119738
10-K2016-03-15fiscal FY 2015301350001047469-16-011178
10-Q2015-11-09fiscal Q3 201527720001104659-15-077270
10-Q2015-08-10fiscal Q2 201523560001104659-15-058302
10-Q2015-05-11fiscal Q1 201523460001104659-15-036849
10-K2015-03-16fiscal FY 2014281130001047469-15-002283
10-Q2014-11-10fiscal Q3 201423580001104659-14-079029
10-Q2014-08-05fiscal Q2 201423580001104659-14-056983
10-Q2014-05-12fiscal Q1 201423480001104659-14-037299
10-K2014-03-12fiscal FY 2013291250001104659-14-018791
10-Q2013-11-12fiscal Q3 201325640001104659-13-083462
10-Q2013-07-22fiscal Q2 201325640001104659-13-055542
10-Q2013-05-06fiscal Q1 201325500001104659-13-037502
10-K2013-03-05fiscal FY 2012331410001047469-13-002200
10-Q2012-11-08fiscal Q3 201233800001193125-12-459621
10-Q2012-08-08fiscal Q2 201231730001193125-12-343543
10-Q2012-05-10fiscal Q1 201229590001193125-12-224497
10-K2012-03-02fiscal FY 201132820001193125-12-093770
10-Q2011-11-04fiscal Q3 201130710000950123-11-095255
10-Q2011-08-09fiscal Q2 201130710000950123-11-074801

Inspect the source

Entity
Oncternal Therapeutics, Inc. / CIK 0001260990
Captured
2026-09-21T17:18:09.927Z
SEC response SHA-256
dcefea30a8ce148cff96c2a2fa09a3b61a34c7954f6f1a0e51956fda420a1d49

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001260990.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))